03:49 PM EST - NexgenRx : NexgenRx posted a first quarter loss of $450,000 or $0.01 per share, compared to a loss of $1.01 million or $0.03 per share in the same period last year. Revenue from transaction fees for the period was $780,000. NexgenRx is a health benefits management company. NexgenRx
shares V.NXG are trading down $0.005 at $0.15.
